For: | Hardinger KL, Brennan DC. Novel immunosuppressive agents in kidney transplantation. World J Transplant 2013; 3(4): 68-77 [PMID: 24392311 DOI: 10.5500/wjt.v3.i4.68] |
---|---|
URL: | https://www.wjgnet.com/2220-3230/full/v3/i4/68.htm |
Number | Citing Articles |
1 |
Karly P. Garnock-Jones. Tacrolimus Prolonged Release (Envarsus®): A Review of Its Use in Kidney and Liver Transplant Recipients. Drugs 2015; 75(3): 309 doi: 10.1007/s40265-015-0349-2
|
2 |
Haiyan Xu, Panpan Dong, Xiaozhou He, Xuyi Ma, Dong Xue, Yanyun Zhang, Xueguang Zhang. B‐cell‐activating factor code and human cytomegalovirus infection in renal transplant recipients. Microbiology and Immunology 2014; 58(8): 439 doi: 10.1111/1348-0421.12167
|
3 |
Ching-Hsia Hung, Shih-Hung Chan, Pei-Ming Chu, Kun-Ling Tsai. Docetaxel Facilitates Endothelial Dysfunction through Oxidative Stress via Modulation of Protein Kinase C Beta: The Protective Effects of Sotrastaurin. Toxicological Sciences 2015; 145(1): 59 doi: 10.1093/toxsci/kfv017
|
4 |
Alexander E Giakoustidis, Dimitrios E Giakoustidis. Immunosuppression Strategies in Liver Transplantation Patient; Patients with Hepatocellular Carcinoma. Immunotherapy 2017; 9(2): 197 doi: 10.2217/imt-2016-0110
|
5 |
Bee Yean Ong, Zoriah Aziz. Efficacy of Cordyceps sinensis as an adjunctive treatment in kidney transplant patients: A systematic-review and meta-analysis. Complementary Therapies in Medicine 2017; 30: 84 doi: 10.1016/j.ctim.2016.12.007
|
6 |
Marta Sobotková, Jiřina Bartůňková. Current trends in immunosuppressive treatment. Vnitřní lékařství 2019; 65(2): 136 doi: 10.36290/vnl.2019.027
|
7 |
Zhila Othman, Khadija Ahmed, Dana Sharif. ORAL MANIFESTATIONS IN RENAL TRANSPLANT RECIPIENTS IN SULAIMANI CITY, KURDISTAN REGION, IRAQ. JOURNAL OF SULAIMANI MEDICAL COLLEGE 2021; 11(1): 85 doi: 10.17656/jsmc.10291
|
8 |
Takayuki Yamamoto, Qi Li, Hidetaka Hara, Liaoran Wang, Hongmin Zhou, Juan Li, Devin E. Eckhoff, A. Joseph Tector, Edwin C. Klein, Ray Lovingood, Mohamed Ezzelarab, David Ayares, Yi Wang, David K.C. Cooper, Hayato Iwase. B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy. Transplant Immunology 2018; 51: 12 doi: 10.1016/j.trim.2018.08.005
|
9 |
Aaron M. Williams, Meredith Barrett, Abigail R. Smith, Ranganath G. Kathawate, Kenneth J. Woodside, Randall S. Sung. Variable Benefits of Antibody Induction by Kidney Allograft Type. Journal of Surgical Research 2020; 248: 69 doi: 10.1016/j.jss.2019.11.015
|
10 |
S Tomasoni, P Trionfini, N Azzollini, L Zentilin, M Giacca, S Aiello, L Longaretti, E Cozzi, N Baldan, G Remuzzi, A Benigni. AAV9-mediated engineering of autotransplanted kidney of non-human primates. Gene Therapy 2017; 24(5): 308 doi: 10.1038/gt.2017.21
|
11 |
Daniel Baron, Magali Giral, Sophie Brouard. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes. Transplant International 2015; 28(8): 938 doi: 10.1111/tri.12578
|
12 |
K.A. Thomas, N.M. Valenzuela, D. Gjertson, A. Mulder, M.C. Fishbein, G.C. Parry, S. Panicker, E.F. Reed. An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA. American Journal of Transplantation 2015; 15(8): 2037 doi: 10.1111/ajt.13273
|
13 |
Ryszard Grenda. Biologics in renal transplantation. Pediatric Nephrology 2015; 30(7): 1087 doi: 10.1007/s00467-014-2886-4
|
14 |
Hani Oweira, Ali Ramouz, Omid Ghamarnejad, Elias Khajeh, Sadeq Ali-Hasan-Al-Saegh, Rajan Nikbakhsh, Christoph Reißfelder, Nuh Rahbari, Arianeb Mehrabi, Mahmoud Sadeghi. Risk Factors of Rejection in Renal Transplant Recipients: A Narrative Review. Journal of Clinical Medicine 2022; 11(5): 1392 doi: 10.3390/jcm11051392
|
15 |
Johann Castañeda-Sanabria, David Hajage, Melisande Le Jouan, Anne Perozziello, Florence Tubach. Off-label use of the expensive orphan drug eculizumab in France 2009–2013 and the impact of literature: focus on the transplantation field. European Journal of Clinical Pharmacology 2016; 72(6): 737 doi: 10.1007/s00228-016-2027-z
|
16 |
Maurizio Salvadori, Giuseppina Rosso, Elisabetta Bertoni. Complement Involvement in Renal Transplantation. EMJ Nephrology 2015; : 63 doi: 10.33590/emjnephrol/10313449
|
17 |
Jiang Qiu, Yehui Chen, Gang Huang, Zhi Zhang, Lizhong Chen, Ning Na. Transforming growth factor‐β activated long non‐coding RNA ATB plays an important role in acute rejection of renal allografts and may impacts the postoperative pharmaceutical immunosuppression therapy. Nephrology 2017; 22(10): 796 doi: 10.1111/nep.12851
|
18 |
Xiao-Hua Yu, Wen-Yi Deng, Hong-Tao Jiang, Tao Li, Yi Wang. Kidney xenotransplantation: Recent progress in preclinical research. Clinica Chimica Acta 2021; 514: 15 doi: 10.1016/j.cca.2020.11.028
|
19 |
Daniel Baron, Magali Giral, Sophie Brouard. Personalized Immunosuppression in Transplantation. 2016; : 177 doi: 10.1016/B978-0-12-800885-0.00008-4
|
20 |
Oleg O. Rummo, Mario Carmellini, Lionel Rostaing, Rainer Oberbauer, Maarten H. L. Christiaans, Christiane Mousson, Robert M. Langer, Franco Citterio, Bernard Charpentier, Malcolm Brown, Gbenga Kazeem, Frank Lehner. ADHERE: randomized controlled trial comparing renal function inde novokidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus. Transplant International 2017; 30(1): 83 doi: 10.1111/tri.12878
|
21 |
B. Wilde, O. Witzke, T. Feldkamp. Biologika als Immunsuppressiva bei Nierentransplantation. Der Nephrologe 2014; 9(3): 239 doi: 10.1007/s11560-014-0862-4
|
22 |
Arun K. Ghosh, Samuel Rodriguez. An enantioselective synthesis of the C3–C21 segment of the macrolide immunosuppressive agent FR252921. Tetrahedron Letters 2016; 57(26): 2884 doi: 10.1016/j.tetlet.2016.05.067
|
23 |
Lisa C. Martial, Bart A. W. Jacobs, Elisabeth A. M. Cornelissen, Anton F. J. de Haan, Birgit C. P. Koch, David M. Burger, Rob E. Aarnoutse, Michiel F. Schreuder, Roger J.M. Brüggemann. Pharmacokinetics and target attainment of mycophenolate in pediatric renal transplant patients. Pediatric Transplantation 2016; 20(4): 492 doi: 10.1111/petr.12695
|
24 |
Angela C Webster, Sunny Wu, Krishna Tallapragada, Min Young Park, Jeremy R Chapman, Sue J Carr. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients. Cochrane Database of Systematic Reviews 2017; 2017(7) doi: 10.1002/14651858.CD004756.pub4
|
25 |
Job C. Tharappel, Curtis E. Bower, Jennifer Whittington Harris, Sandeep K. Ramineni, David A. Puleo, J. Scott Roth. Doxycycline administration improves fascial interface in hernia repair. Journal of Surgical Research 2014; 190(2): 692 doi: 10.1016/j.jss.2014.05.013
|
26 |
Xishao Xie, Yan Jiang, Xiuxiu Lai, Shilong Xiang, Zhangfei Shou, Jianghua Chen. mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis. BMC Nephrology 2015; 16(1) doi: 10.1186/s12882-015-0078-5
|
27 |
Majda Sahman, Snezana Mugosa, Nemanja Rancic. Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study. Frontiers in Public Health 2021; 9 doi: 10.3389/fpubh.2021.671316
|
28 |
Clemens Scheinecker. Blockade of co-stimulation in chronic inflammatory diseases. Wiener Medizinische Wochenschrift 2015; 165(1-2): 23 doi: 10.1007/s10354-014-0313-x
|
29 |
Malte Kölling, George Haddad, Urs Wegmann, Andreas Kistler, Andrea Bosakova, Harald Seeger, Kerstin Hübel, Hermann Haller, Thomas Mueller, Rudolf P Wüthrich, Johan M Lorenzen. Circular RNAs in Urine of Kidney Transplant Patients with Acute T Cell-Mediated Allograft Rejection. Clinical Chemistry 2019; 65(10): 1287 doi: 10.1373/clinchem.2019.305854
|
30 |
Chen-Liang Chou. Braddom's Rehabilitation Care: A Clinical Handbook. 2018; : 190 doi: 10.1016/B978-0-323-47904-2.00028-3
|
31 |
Amitava Dasgupta. Personalized Immunosuppression in Transplantation. 2016; : 29 doi: 10.1016/B978-0-12-800885-0.00002-3
|
32 |
Martin Wagner, Amy K Earley, Angela C Webster, Christopher H Schmid, Ethan M Balk, Katrin Uhlig. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients. Cochrane Database of Systematic Reviews 2015; 2015(12) doi: 10.1002/14651858.CD007746.pub2
|
33 |
E. Ono, A.M. dos Santos, P.O. Viana, M.I.S. Dinelli, N. Sass, L. De Oliveira, A.L. Goulart, M.I. de Moraes-Pinto. Immunophenotypic Profile and Increased Risk of Hospital Admission for Infection in Infants Born to Female Kidney Transplant Recipients. American Journal of Transplantation 2015; 15(6): 1654 doi: 10.1111/ajt.13143
|
34 |
Elizabeth G. Ingulli, Stephen I. Alexander, David M. Briscoe. Pediatric Nephrology. 2016; : 2457 doi: 10.1007/978-3-662-43596-0_64
|
35 |
Veruschka Albert, Gerhard Piendl, Dali Yousseff, Hedwig Lammert, Michael Hummel, Olaf Ortmann, Wolfgang Jagla, Andreas Gaumann, Anja K. Wege, Gero Brockhoff. Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effects. Archives of Gynecology and Obstetrics 2022; 306(4): 1197 doi: 10.1007/s00404-022-06434-2
|
36 |
Elizabeth Ingulli, Stephen I. Alexander, David M. Briscoe. Pediatric Nephrology. 2015; : 1 doi: 10.1007/978-3-642-27843-3_64-1
|
37 |
Johan M Lorenzen, Celina Schauerte, Malte Kölling, Anika Hübner, Monika Knapp, Hermann Haller, Thomas Thum. Long Noncoding RNAs in Urine Are Detectable and May Enable Early Detection of Acute T Cell–Mediated Rejection of Renal Allografts. Clinical Chemistry 2015; 61(12): 1505 doi: 10.1373/clinchem.2015.243600
|